Zhongwen X.

Zhongwen X. has a diverse work experience spanning multiple companies and roles. They began their professional career in 2013 with internships at Prosetta Corporation and the UCSF Radiopharmaceutical Department. In 2016, they worked as a Lab Technician at Invitrx Therapeutics, where they performed various tasks related to PRP and PBMC extraction, as well as sales and inventory management. Later that year, they served as a Project Assistant at Genetech Inc.

In 2017, Zhongwen joined Kite Pharma as a Cell Therapy Specialist, a position they held until 2019. During this time, they likely gained expertise in cell therapy-related activities. In 2019, Zhongwen transitioned to Adaptive Biotechnologies Corp., where they initially worked as a Research Associate III. In this role, they collaborated with cross-functional teams to develop and optimize T-cell culture experiments. They also executed TCR discovery experiment protocols, analyzed results, optimized conditions, and resolved issues. In 2021, Zhongwen took on the role of Process Development Engineer at A2 Biotherapeutics, Inc., where they are currently employed.

Overall, Zhongwen X. has demonstrated a strong foundation in scientific research and development, with a focus on biotechnological and therapeutic applications.

Zhongwen X has a diverse educational background. They are currently pursuing a Master's Degree in software engineering from Harvard Extension School, with an expected completion date in 2022. Prior to this, Zhongwen obtained a certification in Project Management from UCLA Extension in 2018. In 2017, they completed a Master's Degree in Biomedical/Medical Engineering from UC Irvine. Their undergraduate studies were focused on Chemical Engineering, as they received a Bachelor's Degree from UCLA in 2012. Before attending UCLA, Zhongwen attended City College of San Francisco from 2007 to 2010, where they studied Stem Cell Technology. Additionally, Zhongwen has obtained several certifications, including BD FACSAria Fusion Operation from BD in 2019, another Project Management certification from UCLA Extension in 2018, Pluripotent Stem Cell Training from Thermo Fisher Scientific in 2016, and Stem Cell Technology from City College of San Francisco in 2013.